Article
Analysis of a detoxified <i>Escherichia coli</i> strain for bacteriophage production
2026-04-21
Abstract excerpt
Phage therapeutics are re-emerging as adjuncts or alternatives to antibiotics and their clinical translation will be enhanced with production methods that minimise downstream processing. We evaluated whether an endotoxin-reduced E. coli strain developed for production of recombinant proteins, ClearColi®, can serve as a useful, safe phage production host without compromising yield and whether targeted receptor com...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- ed5b2a99-bcde-5174-9f8f-3fd1c7c40cb5
- DOI
- 10.64898/2026.04.21.719556
